ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.308,12
0,76%
Dow Jones
39.184,21
0,30%
Euro vs US Dollar
1,08494
0,34%
Bitcoin
68.139,83
0,32%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Taysha Gene Therapies Inc (TSHA)

  7. Taysha Gene Therapies Inc (TSHA) News

TSHA

Taysha Gene Therapies (TSHA)

Taysha Gene Therapies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TSHA
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
14/05/202422h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
14/05/202422h01GlobeNewswire Inc.Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
07/05/202422h05GlobeNewswire Inc.Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14NASDAQ:TSHATaysha Gene Therapies Inc
03/05/202422h05GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
02/05/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
05/04/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
20/03/202418h30AllPennyStocks.comAnother Biotech Steals The Show Following Major Clinical Data ReleaseNASDAQ:TSHATaysha Gene Therapies Inc
19/03/202421h01GlobeNewswire Inc.Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
19/03/202412h27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:TSHATaysha Gene Therapies Inc
14/03/202421h26GlobeNewswire Inc.Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19NASDAQ:TSHATaysha Gene Therapies Inc
01/03/202423h08GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
29/02/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
15/02/202422h01GlobeNewswire Inc.Taysha Gene Therapies Provides Update on Deprioritized Pipeline ProgramsNASDAQ:TSHATaysha Gene Therapies Inc
09/02/202422h24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TSHATaysha Gene Therapies Inc
02/02/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
22/01/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual ConferenceNASDAQ:TSHATaysha Gene Therapies Inc
10/01/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
10/01/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
05/01/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
20/12/202322h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
20/12/202322h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TSHATaysha Gene Therapies Inc
19/12/202313h30PR Newswire (US)Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene TherapiesNASDAQ:TSHATaysha Gene Therapies Inc
29/11/202314h00GlobeNewswire Inc.Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome PatientsNASDAQ:TSHATaysha Gene Therapies Inc
15/11/202322h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
14/11/202322h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
14/11/202322h08GlobeNewswire Inc.Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
07/11/202314h00GlobeNewswire Inc.Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14NASDAQ:TSHATaysha Gene Therapies Inc
03/11/202321h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
03/11/202321h40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:TSHA

Kürzlich von Ihnen besucht

TG
432
Arbor Metals
NYSE
KO
Coca Cola
USOTC
BNPQY
BNP Paribas (QX)
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
TG
NOV
Novo Nordisk
NASDAQ
NVDA
NVIDIA
TG
MBG
MercedesBenz
TG
BAS
BASF
TG
RHM
Rheinmetall
AMEX
SPY
SPDR S&P 500
TG
CBK
Commerzbank
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten